Prostate Cancer And Immunotherapy With Dr. Ana Aparicio

Prostate Cancer and Immunotherapy with Dr. Ana Aparicio

Cancer Research Institute

Ana Aparicio, MD, on immunotherapy as a future treatment guideline for metastatic prostate cancer

Ana Aparicio, MD, discusses where chemotherapy fits in regard to prostate cancer treatment

Ana Aparicio, MD, discusses the impact of CHAARTED and STAMPEDE on her treatment decisions

Immunotherapy & Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Prostate Cancer Research Institute

Immunotherapy in prostate cancer

Management of Aggressive Prostate Cancer Variants

Prostate Cancer Research: Is there a future for immunotherapy?

Dana-Farber Cancer Institute

Ana Aparicio, MD, on metastatic castration-resistant prostate cancer patients and chemotherapy

Immunotherapy and Advanced Prostate Cancer

University of California Television (UCTV)

Enhancing the efficacy of immunotherapy in prostate cancer

Immunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MD

Prostate Cancer Research Institute

Ana Aparicio, MD, on how to sequence commonly used agents in metastatic prostate cancer

Vaccines are a promising direction for prostate cancer immunotherapy

Can vaccines and immune checkpoint inhibitors work together to treat prostate cancer?

Ana Aparicio, MD, explains data and conclusions from her presentation at ASCO GU 2017

Prostate Cancer Genetics and Immunotherapy in Prostate Cancer Treatment

NYU Langone Health

Prostate Cancer Immunotherapy with Dr. Sumit Subudhi

Cancer Research Institute

What is PROVENGE? Learn about Immunotherapy for Prostate Cancer

Prostate Cancer Research Institute

Immunotherapy In 2021, Mark Scholz, MD, Prostate Cancer Support Association of New Mexico

Prostate Cancer Research Institute